ALT is an enzyme found predominantly in liver cells. When liver cells are damaged or inflamed, ALT leaks into the bloodstream, making it one of the most liver-specific markers available in standard bloodwork.
ALT is the primary marker for detecting liver inflammation or damage. Mildly elevated ALT is most commonly caused by fatty liver disease (NAFLD/MASLD), alcohol use, medications, or viral hepatitis, in that approximate order of prevalence in the general population. The longevity consensus targets lower than standard clinical ranges: values above 25-30 U/L warrant attention even though clinical "normal" extends to 40 or higher. Persistently elevated ALT, even mildly, is one of the earliest warnings of metabolic-driven liver disease.
Optimal ALT: 10-25 U/L.
Typically re-tested every 10 weeks.
ALT appears on almost every routine chemistry panel, usually beside AST, ALP, GGT, bilirubin and albumin. Read together, those markers tell a more useful story than ALT alone, because the pattern across them points in a direction that one isolated value never can.
ALT is an enzyme that helps cells convert the amino acid alanine into usable energy substrates, and because it is most concentrated in liver cells, the amount circulating in blood is used as a marker of liver cell integrity.
The older name, SGPT (serum glutamic pyruvic transaminase), describes the same enzyme and the same test. Labs and lab reports use the two names interchangeably, so ALT, SGPT and ALT/SGPT on a results page all refer to one measurement, reported in units per litre (U/L).
The mechanism is simple. ALT normally lives inside hepatocytes, the working cells of the liver. When a hepatocyte is stressed, inflamed or damaged, its membrane becomes leakier and enzyme escapes into the bloodstream, where a blood draw can pick it up. The enzyme is also present in smaller amounts in skeletal muscle, the kidneys and the heart, but the liver contribution dominates, which is why guideline discussion of abnormal liver chemistries regards ALT as the more liver-specific of the two classic transaminases[1].
Two things follow from that. First, ALT is a leakage marker, not a function marker. It reports that cells are releasing enzyme, not how well the liver is synthesising proteins or clearing waste. Second, the size of the number is not a clean measure of how much liver tissue is involved. A modest, persistent elevation can matter more over years than a single sharp spike after a hard training week.
ALT matters because it is one of the earliest and cheapest signals that the liver is carrying a metabolic load, often long before any symptom shows up.
The liver sits at the centre of how the body handles glucose, insulin, fat and alcohol. When excess energy is stored as fat inside liver cells, those cells become inflamed and leak enzyme. That pattern is the common reason a healthy-feeling adult sees a mildly raised ALT on a routine panel, and it is the reason the marker gets attention in metabolic medicine rather than only in hepatology.
The long-term relevance is mostly about trajectory. Research suggests that raised liver enzymes are associated with a higher likelihood of developing type 2 diabetes, and an umbrella review of meta-analyses of diabetes risk factors includes liver enzyme elevation among the exposures with supporting evidence[2]. Association is not causation, and no single enzyme predicts an individual's future. What it does give you is an early place to look. Clinical practice guidance on the care of patients with obesity also treats hepatic steatosis as a complication worth identifying and monitoring rather than an incidental finding[3].
There is a second reason to track it. ALT responds to change. Body composition shifts, alcohol intake, dietary pattern and medication changes can all move the number within months, which makes it a practical feedback marker when you are measuring the same thing repeatedly rather than once.
A typical lab reference range for ALT spans roughly 7 to 56 U/L, while FitScript's optimal range is tighter at 10 to 25 U/L.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| ALT (SGPT), serum | 7 to 56 U/L | 10 to 25 U/L |
An IFCC multicenter study of 765 carefully selected healthy adults (411 women, 354 men) aged 18 to 85 from Italy, China, Turkey and the Nordic countries.[13] Men had a clearly higher range than women.[13]
| Sex | Age | Reference range (U/L) |
|---|---|---|
| Men | 18 to 85 | 9 to 59 |
| Women | 18 to 85 | 8 to 41 |
The study measured ALT with methods standardized to the IFCC reference system and split the interval by sex only, because the sex difference was significant.[13] Your own lab's printed range is the one to read your result against.
Reference ranges vary by lab, age and sex, and the assay method and reporting units differ between providers, so always read your result against the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is not a finding on its own.
The gap between the two columns is worth understanding. Conventional reference intervals are derived statistically from a sampled population, and guideline commentary on abnormal liver chemistries has noted that those populations can include people with unrecognised liver disease, which pushes the upper limit higher than the values seen in genuinely healthy reference groups[1]. That is why a result in the high 30s or 40s can be flagged as normal by a lab and still be worth a conversation about metabolic health.
It also cuts the other way. A result just below an optimal band is not a problem to solve in isolation. What matters is the direction across repeat tests and the company the value keeps on the rest of the panel.
A high ALT means more enzyme than expected is leaking out of liver cells, and the useful question is always why, not how high.
What people report. Most mild elevations produce no symptoms at all, which is exactly why the marker is useful. When symptoms do accompany a raised result, people commonly describe fatigue that does not match their sleep, a dull ache or fullness under the right ribs, nausea or poor appetite, and less often darker urine, pale stools, itching skin or yellowing of the eyes. Those last few are reasons to contact a clinician promptly rather than wait for the next scheduled test.
Common reasons it rises. Fat accumulation in the liver linked to insulin resistance and excess body fat is the most frequent explanation in adults who feel well. Alcohol intake, viral hepatitis, medications and some supplements, recent intense or unaccustomed exercise, muscle injury, coeliac disease, thyroid disorders and inherited conditions such as haemochromatosis also appear on the standard list that clinicians work through when liver chemistries are abnormal[1]. In pregnancy, raised transaminases alongside bile acids form part of the picture clinicians assess in intrahepatic cholestasis of pregnancy, where pooled analyses have linked biochemical markers to perinatal outcomes[4]. Environmental exposure is an active research area too, and a systematic review and meta-analysis reported an association between exposure to per- and polyfluoroalkyl substances and markers of liver injury including ALT[5].
Why persistence matters. A one-off elevation after a marathon or a heavy weekend often settles on retesting. A value that stays suboptimal across months is the one that deserves a structured workup, because ongoing hepatocyte inflammation is the process that drives fibrosis over years, and because the same metabolic conditions that raise ALT are associated with cardiometabolic risk more broadly[2].
Observation, then meaning, then next step. The observation is enzyme leakage. The meaning is a liver under some form of load, which could be metabolic, toxic, viral, muscular or medication-related. The next step is a repeat test under controlled conditions plus a clinician reviewing the full panel and your history. Never ignore a flagged result because you feel fine.
A low ALT is usually unremarkable on its own, and in most contexts it reflects low enzyme turnover rather than a problem with the liver.
What people report. Typically nothing. Low ALT does not produce symptoms, and it is almost never the reason someone feels unwell. When it shows up alongside complaints, those complaints tend to be general, such as reduced strength, slower recovery or unintended loss of weight in older adults.
Common reasons it falls. Two explanations come up most. The first is low skeletal muscle mass, since muscle contributes some circulating enzyme and ALT tends to track body composition. A systematic review and meta-analysis of blood biomarkers for sarcopenia examined ALT among the candidate markers studied for diagnostic accuracy in that setting, reflecting the interest in this relationship[6]. The second is vitamin B6 status, because the ALT reaction depends on pyridoxal 5-phosphate as a cofactor, so low availability can reduce measured activity. Pregnancy, and simply being at the naturally lower end of a healthy distribution, also account for many low readings.
What it may signal over time. In older populations, low ALT can appear alongside frailty, reduced muscle mass and poorer functional reserve, which is why it is read as a body-composition and nutrition signal rather than a liver signal in that group. In a younger, active adult with normal strength and nutrition, a low-normal ALT is generally a non-event. The next step, if anything, is a conversation about protein intake, resistance training and overall nutritional status with a clinician who can see the whole picture.
ALT moves for reasons that have nothing to do with liver disease, which is why testing conditions and context matter as much as the number itself.
Testing conditions. Pre-analytical factors shift biochemical results more than most people expect. Haemolysis during the draw, delays before centrifugation, storage temperature and sample handling all influence measured analytes, and a systematic review of pre-analytical variation documents how substantially these steps affect stability[7]. Drawing at a consistent time of day, from the same lab, under similar conditions, makes serial comparison far more meaningful.
Activity and body composition. Strenuous or unaccustomed exercise in the days before a draw can raise transaminases from muscle as well as liver. Rapid weight change, both gain and loss, also moves liver enzymes.
Medications and supplements. A wide range of prescription medicines, over-the-counter products and herbal supplements influence liver enzymes, and monitoring of liver chemistries is a standard part of care with several drug classes. Cochrane evidence on statin therapy in children with familial hypercholesterolaemia, for example, includes liver enzyme outcomes among the safety measures assessed[8]. Supplements are not neutral either. A meta-analysis of randomised trials of berberine supplementation reported effects on liver function enzymes among its outcomes[9], and a systematic review of dietary polyphenol supplementation in non-alcoholic fatty liver disease also examined changes in liver enzymes[10]. Any such effects are modest and not settled, and none of this is a reason to start or stop anything without a licensed provider reviewing it.
Diet and alcohol. Alcohol intake in the days before a test is a common and underreported influence. Dietary sugar matters too, and a systematic review and meta-analysis of controlled trials found that important food sources of fructose-containing sugars were associated with measures relevant to non-alcoholic fatty liver disease[11]. The practical takeaway is to keep the week before a retest representative of your normal life, not artificially clean, unless your clinician asks otherwise.
ALT is measured as part of the standard liver chemistry group within FitScript's blood work, which covers 150+ biomarkers tested per year so the enzyme is read in context rather than in isolation.
The value of repeat testing is pattern recognition. One ALT tells you where you are today. Three or four across a year tell you whether a number is drifting, settling or responding to something you changed. Atlas, FitScript's AI health advisor, reads the result against the rest of the panel, flags the combinations worth attention, and writes your FitScript, the personalised output built from your own biology rather than a population average.
Where a result points toward metabolic liver involvement, the options discussed range from nutrition and training changes through to prescription therapies. GLP-1-based therapies are one current area of interest, and a systematic review and meta-analysis has examined their efficacy in metabolic dysfunction-associated steatotic liver disease and steatohepatitis[12]. Whether any prescription therapy is appropriate for a given person is a decision a licensed provider makes after reviewing that person, their labs and their history. No article, and no algorithm, makes that call.
ALT is printed on the liver panel and the comprehensive metabolic panel, sometimes as SGPT on older reports, in units per liter (U/L). An H flag means the result is above that lab's own reference interval, and it is read with AST, alkaline phosphatase and bilirubin.
ALT becomes genuinely informative when it is read beside four or five companions, because the pattern across them narrows the field in a way one enzyme cannot.
The second transaminase is the first comparison most clinicians make, since the ratio between the two enzymes shifts with different underlying processes. The biliary enzymes come next, because a rise concentrated in those markers points toward bile flow rather than hepatocyte leakage. Triglycerides and fasting insulin connect the liver picture to the metabolic one, and they often move together when fat accumulation is the driver. Albumin adds the synthetic side of the story, reporting on what the liver is making rather than what it is leaking.
To explore each one, see the biomarker guides for AST, GGT and Alkaline Phosphatase on the liver side, Triglycerides and Fasting Insulin on the metabolic side, and Albumin for liver synthetic capacity. The Metabolic + Insulin panel groups several of these markers so they can be read together from a single draw.
ALT, also written SGPT, is a liver enzyme measured in blood as a marker of hepatocyte stress. Typical lab ranges run to 56 U/L, FitScript's optimal range is 10 to 25 U/L, and the direction of travel across repeat tests usually tells you more than any single value. High results most often reflect metabolic load on the liver, low results more often reflect muscle mass or nutritional status, and both are findings to interpret rather than conclusions to act on alone.
This article is educational and is not medical advice. Discuss your results, and any treatment decision, with a clinician or licensed provider who can review your full history.
Calculators that use ALT:
Yes. SGPT (serum glutamic pyruvic transaminase) is the older name for alanine aminotransferase. Lab reports may print ALT, SGPT or ALT/SGPT, and all three refer to the same enzyme and the same measurement, reported in units per litre.
A typical lab reference range runs around 7 to 56 U/L, and FitScript's optimal range is 10 to 25 U/L. Reference ranges vary by lab, age and sex, so read your value against the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off.
ALT itself is not strongly fasting-dependent, but it is usually drawn as part of a panel that includes markers such as glucose and triglycerides, which are. Follow the fasting instructions your lab or clinician gives for the full panel, and keep conditions consistent between tests so results are comparable.
Yes. Strenuous or unaccustomed exercise in the days before a draw can raise transaminases from skeletal muscle as well as from the liver. If a result comes back elevated after a heavy training block, clinicians often repeat the test after a period of lighter activity before investigating further.
Most mild ALT elevations cause no symptoms, which is why routine panels catch them. A raised value indicates enzyme leaking from liver cells, commonly linked to fat accumulation in the liver, alcohol, medications, supplements or recent exercise. It is worth discussing with a clinician and repeating rather than dismissing.
A low ALT is usually unremarkable and does not point to liver trouble. It is more often read as a signal about muscle mass, nutritional status or vitamin B6 availability, particularly in older adults. It is worth mentioning at your next clinician review alongside strength, protein intake and body composition.
That depends on why it was flagged and what else appears on the panel, so the interval is a clinician decision. In general, repeat testing under similar conditions is what makes the marker useful, because the direction of travel across several results carries more information than any single value.
AST, GGT, alkaline phosphatase, bilirubin and albumin fill in the liver picture, while triglycerides and fasting insulin connect it to metabolic health. The pattern across those markers, rather than ALT alone, is what guides a clinician toward the likely explanation.